Biotech
> HemoShear named its chief business officer, Vincent Aurentz, as president. Release
> Seres Therapeutics adds Dr. Dennis Ausiello to its board of directors. Release
> Jeffrey Kasher joins DrugDev as chairman of its advisory board. Release
> Former Elan CEO G. Kelly Martin becomes chairman of Serenus' board of directors. Release
> Neos Therapeutics appoints Paul Edick and John Schmid to its board of directors. Release
> AMAG Pharmaceuticals ($AMAG) appointed Aaron Pelta as vice president of business development. Release
> Scynexis ($SCYX) appoints Guy Macdonald as chairman of its board of directors. Release
> Qu Biologics names Jim Pankovich as vice president of clinical operations and drug development. Release
> Medgenics ($MDGN) added Barbara Duncan to its board of directors. Release
> Dimension Therapeutics appoints George Migausky to its board of directors. Release
> Bioventus promoted Andrew Hosmer to managing director, international with responsibility for Europe, Middle East and Africa, and Isabelle Levy-Unger to managing director, international, with responsibility for Canada, Latin America and Asia-Pacific. Release
> Verastem ($VSTM) announced that Dr. Joanna Horobin, chief medical officer, will transition to senior adviser, while Dr. Lou Vaickus will serve as interim CMO. Release
> Endomag appointed Dr. Elizabeth Holmes as chief medical officer. Release
> Alnylam ($ALNY) appointed David-Alexandre Gros as its senior vice president and chief business officer. Release
> Mark Baldry joined Amicus Therapeutics as the company's vice president of global marketing, and Willem van Weperen also joined as regional vice president and country manager. Release
> Conatus Pharma appointed Jean Chan as its vice president of clinical development. Release
> Lion Biotechnologies named Molly Henderson as its chief financial officer. Release
> Xbiotech appointed Kelly Thornburg as its senior vice president of operations. Release
> Floyd Fox joined FlowMetric as its chief scientific officer. Release
> Opexa brought on Jason Kralic as the company's vice president of business development. Release
> Alex Drijver joined ComInnex as its CEO. Release
Pharma
> Shire ($SHPG) appoints Smith & Nephew ($SNN) CEO Olivier Bohuon to its board of directors. Release
> Valeant ($VRX) appointed Robert Rosiello as executive vice president and chief financial officer. Release
> Johnson & Johnson ($JNJ) adds Mary Beckerle, CEO and director of Huntsman Cancer Institute, to its board of directors. Release
> Tarsis Lopez joined Astellas Pharma's corporate affairs department. Release
Drug Delivery
> BioDelivery Science International ($BDSI) hired Stephana Patton as its general counsel. Release
|